Corporate Support
8735 W. Higgins Road Suite 300 Chicago, IL 60631
Tel: (847)375-6340 Email:

Search our Site

Corporate Support

Learn more and join our Industry Relations Council

Advertise with ITNS

Advertise with ITNS

Website Ads

Advertise on the ITNS website for exclusive placement that will give your company the attention it deserves. To learn more about these limited opportunities, contact our publishing partner Multiview at 972-402-7023 or

$500 / month - provides your company banner on a web page (other than the home page) with a direct link to a designated URL.

Please submit graphic art in .jpg format following the guidelines for pixel size below:

  • To fit the main Body Column, the graphic should be no wider than 450px and no higher than 150px.
  • To fit the Right Column, the graphic should be no wider than 240px and no higher than 240px.
  • Flash files must be submitted in the .swf format using the same pixel sizes as listed above. File size should not exceed 1MB).

Advertising questions can be directed to:

Tel + 1 847.375.6340
Fax +1 847.375.6341

Web Site Sponsor
$7,500 / 1-year - provides your company logo on the ITNS web site home page with a direct link to a designated URL.

Blast Email

Please review the blast email application for guidelines and submission requirements.

Mailing Labels

Strictly for the dissemination of transplant-related educational announcements, ITNS provides mailing labels. Materials must be approved by ITNS Headquarters. The labels are priced at .50 cents per address, with a minimum cost of $100 per order per usage. Labels are sent electronically in Excel format. ITNS Label Order Form (PDF)

Advertise on the Career Center

Want to advertise a position?

Does your organization have a job opening available for healthcare workers interested in transplantation? Please post your available transplant positions on the ITNS web site Career Opportunities page. Reach high-quality candidates through the ITNS Career Center and their alliance with the National Healthcare Career Network (NHCN). The NHCN links job boards of leading healthcare associations – the preferred resource for healthcare talent.
View the posting rates to see the single rate and discounts for placing multiple listings.

Advertise on the Career Center with a Banner Ad

Fill out the advertising form to post a banner on the ITNS Career Center page.
Interested in advertising on the ITNS Career Center? Contact Mary Paulson for more information at Are you thinking about changing jobs but would like to remain within the transplantation field? Visit Career Opportunities frequently for new openings. Job seekers can post their professional profile for free! 

ITNS Webinar Promotion

Promote your webinar on the ITNS website to ITNS members. Please refer to the application for guidelines and submission requirements.

Industry Relations Council (IRC)

The ITNS Industry Relations Council is available to organizations that support the goals and mission of ITNS and provide products or services used in the area of transplantation. Membership is for one year. It is a nonvoting membership with benefits extended to a single corporate-designated representative. Membership is available at an associate or executive level. Read about the benefits of joining the IRC and apply today.


Executive Level


 AstellasTransplant RGB


Astellas Pharma US, Inc.
1 Astellas Way
Northbrook, IL 60062

Astellas Pharma US, Inc. is the headquarters for the Americas for Astellas Pharma (Toyko). Astellas is a pharmaceutical company dedicated to improving the health of people around the world by providing innovative and reliable products in the areas of cardiology, dermatology, infectious disease, oncology, transplant and urology.


Veloxis logo RGB 300dpi


Veloxis Pharmaceuticals
1001 Winstead Drive, 3rd floor, Suite 310
Cary, North Carolina 27513

Veloxis Pharmaceuticals (Veloxis) is a specialty pharmaceutical company focused on the development and commercialization of a novel product for the prevention of organ rejection in kidney transplant patients. All clinical studies including two Phase III trials, have successfully been completed and a New Drug Application (NDA) was submitted to the U.S. Food and Drug Administration (FDA) in December 2013 seeking approval for the marketing and sale. Veloxis is commited to ensuring access to ENVARSUS XR regardless of a patient's insurance or financial situation. Patient Financial Support Resources